Job cuts at home-grown pharma companies like Arvinas and RallyBio and federal policies challenge CT biotech 'ecosystem' that ...

For the better part of six years, developers have their sights set on building a 2.5-million-square-foot biotechnology- and ...

ReproNovo has licensed rights to two drugs from Mereo BioPharma and ObsEva that it thinks could address fertility issues in ...

That’s because the ‘world’s first’ contraceptive implant for men could be coming soon to a penis near you – but you’ve to be ...

Texas A&M AgriLife opened its new Animal Reproductive Biotechnology Center on Tuesday afternoon despite the rainy conditions. The Biotechnology Center is a state-of-the-art, 27,000 square-foot ...

Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter Memphasys Limited, the ASX-listed reproductive biotechnology company, reported significant ...

Memphasys Limited, the ASX-listed reproductive biotechnology company, reported significant accomplishments in 2024, focusing on cost reduction and product development, including the RoXsta ...

He added that they decided to raise a round earlier this year because they thought it made sense to as a reproductive health company amid the uncertainty surrounding the results of Tuesday’s U.S ...

The atmosphere was charged with the collective determination of those who felt betrayed by this swift, out-of-touch ruling that swiped away our already tenuous reproductive and privacy rights.

The result was Hertility, which seeks to provide more personalized testing and services, including diagnostic testing, egg freezing, and telemedicine, to women through their reproductive journeys.

Reproductive healthcare information can be obtained by public health entities, auditors and some other parties when the information is not being used against the patient.